SS

Semil Shailesh Shah

Active Director Director DIN 10905791
DIN 10905791 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Semil Shailesh Shah

Data last updated:

Semil Shailesh Shah is a Director at Veriton Pharma Private Limited (since 2025). The company operates in Pharma.

DIN 10905791
Primary Designation Director
Industry Pharma
First Appointment 17 Jan 2025
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Veriton Pharma Private Limited U24239GJ2020PTC115392
Director17 Jan 20252020Active

Directorship timeline

Open interactive timeline →
Veriton Pharma Private Limited
Premium access

Shareholding and investment profile for Semil Shailesh Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Semil Shailesh Shah

Semil Shailesh Shah currently holds 1 directorship: Veriton Pharma Private Limited (Director, since 17 Jan 2025).

Semil Shailesh Shah was first appointed on 17 Jan 2025 as Director at Veriton Pharma Private Limited.

The current boards of Semil Shailesh Shah's companies include Darshan Prakashkumar Shah (Veriton Pharma Private Limited), Nitesh Karshanbhai Ladva (Veriton Pharma Private Limited), Pavankumar Sharadbhai Nasit (Veriton Pharma Private Limited), Rahil Pinakin Shah (Veriton Pharma Private Limited), Vijay Ganpatbhai Patel (Veriton Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available